The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

The JV will focus on discovering and developing new drugs for conditions ... of blindness called Stargardt. Bayer is just the latest in a string of big pharma companies to invest in firms with ...

Similiar legislation died last year after getting House approval.

Bayer has joined its peers among European drugmakers ... There were also modest gains for the company's consumer health and crop science divisions, although restructuring costs dragged down ...

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

Transfer news LIVE! Arsenal to pay Williams clause, Sesko blow; Man Utd complete Dorgu deal; Tel to Chelsea - Premier League ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Dubai, UAE: MSD, a leading biopharmaceutical company, has established a new office in Dubai, further solidifying its ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...